ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 172 filers reported holding ACCELERON PHARMA INC in Q3 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $29,000 | -14.7% | 726 | -13.2% | 0.00% | 0.0% |
| Q2 2019 | $34,000 | -89.7% | 836 | -88.2% | 0.00% | -87.5% |
| Q1 2019 | $329,000 | +6.5% | 7,062 | -0.6% | 0.01% | -11.1% |
| Q4 2018 | $309,000 | -56.4% | 7,106 | -42.5% | 0.01% | -47.1% |
| Q3 2018 | $708,000 | +15.7% | 12,364 | -1.9% | 0.02% | +6.2% |
| Q2 2018 | $612,000 | +39.4% | 12,606 | +12.4% | 0.02% | +33.3% |
| Q1 2018 | $439,000 | – | 11,220 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |